Literature DB >> 21396157

Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.

Dominik Cholewa1, Thomas Stiehl, Anne Schellenberg, Gudrun Bokermann, Sylvia Joussen, Carmen Koch, Thomas Walenda, Norbert Pallua, Anna Marciniak-Czochra, Christoph V Suschek, Wolfgang Wagner.   

Abstract

The composition of mesenchymal stromal cells (MSCs) changes in the course of in vitro culture expansion. Little is known how these cell preparations are influenced by culture media, plating density, or passaging. In this study, we have isolated MSCs from human adipose tissue in culture medium supplemented with either fetal calf serum (FCS) or human platelet lysate (HPL). In addition, culture expansion was simultaneously performed at plating densities of 10 or 10,000 cells/cm(2). The use of FCS resulted in larger cells, whereas HPL significantly enhanced proliferation. Notably, HPL also facilitated expansion for more population doublings than FCS (43 ± 3 vs. 22 ± 4 population doubling; p < 0.001), while plating density did not have a significant effect on long-term growth curves. To gain further insight into population dynamics, we conceived a cellular automaton model to simulate expansion of MSCS. It is based on the assumptions that the number of cell divisions is limited and that due to contact inhibition proliferation occurs only at the rim of colonies. The model predicts that low plating densities result in more heterogeneity with regard to cell division history, and favor subpopulations of higher migratory activity. In summary, HPL is a suitable serum supplement for isolation of MSC from adipose tissue and facilitates more population doublings than FCS. Cellular automaton computer simulations provided additional insights into how complex population dynamics during long-term expansion are affected by plating density and migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396157     DOI: 10.3727/096368910X557218

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  42 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 2.  Serum-free media for the production of human mesenchymal stromal cells: a review.

Authors:  S Gottipamula; M S Muttigi; U Kolkundkar; R N Seetharam
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

3.  The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells.

Authors:  Ruurd Torensma; Henk-Jan Prins; Ellen Schrama; Eugène T P Verwiel; Anton C M Martens; Helene Roelofs; Bastiaan J H Jansen
Journal:  Stem Cells Dev       Date:  2012-12-21       Impact factor: 3.272

Review 4.  Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience.

Authors:  Eva Rubio-Azpeitia; Isabel Andia
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

5.  Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula.

Authors:  Yong Beom Cho; Kyu Joo Park; Sang Nam Yoon; Kee Ho Song; Do Sun Kim; Sang Hun Jung; Mihyung Kim; Hee Young Jeong; Chang Sik Yu
Journal:  Stem Cells Transl Med       Date:  2015-03-31       Impact factor: 6.940

Review 6.  Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

Authors:  Ann De Becker; Ivan Van Riet
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

7.  Culture of human cell lines by a pathogen-inactivated human platelet lysate.

Authors:  R Fazzina; P Iudicone; A Mariotti; D Fioravanti; A Procoli; E Cicchetti; G Scambia; G Bonanno; L Pierelli
Journal:  Cytotechnology       Date:  2015-05-06       Impact factor: 2.058

8.  High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells.

Authors:  Amel Dudakovic; Emily Camilleri; Scott M Riester; Eric A Lewallen; Sergiy Kvasha; Xiaoyue Chen; Darcie J Radel; Jarett M Anderson; Asha A Nair; Jared M Evans; Aaron J Krych; Jay Smith; David R Deyle; Janet L Stein; Gary S Stein; Hee-Jeong Im; Simon M Cool; Jennifer J Westendorf; Sanjeev Kakar; Allan B Dietz; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2014-10       Impact factor: 4.429

9.  Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.

Authors:  Kaifeng Shao; Carmen Koch; Manoj K Gupta; Qiong Lin; Michael Lenz; Stephanie Laufs; Bernd Denecke; Manfred Schmidt; Matthias Linke; Hans C Hennies; Jürgen Hescheler; Martin Zenke; Ulrich Zechner; Tomo Šarić; Wolfgang Wagner
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

Review 10.  Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells.

Authors:  Darwin J Prockop
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.